Literature DB >> 168694

[A spectrophotometric method for the determination of serum cholinesterase variants with succinyl choline as substrate (author's transl)].

D P Agarwal, S Schwenkenbecher, L M Srivastava, H W Goedde.   

Abstract

A simple and rapid method for the estimation of the hydrolysis of succinyl choline by serum cholinesterase variants is described. Succinyl choline, as substrate for the enzyme assay, has many advantages over other substrates (acetyl choline, benzoyl choline and butyryl choline) which have no clinical application. Choline, the hydrolytic product of succinyl choline, is oxidized to betaine aldehyde by choline oxidase (EC 1.1.99.1), a rat liver mitochondrial preparation; this is coupled to the reduction of cytochrome c which is measured at 550 nm. Fifty normal sera (UU), 17 heterozygous (UA) and 8 atypical (AA) were tested with this method, and on the basis of resistance to dibucaine (Cinchocain; Kalow, W. & Genest, K. (1957) Canad. J. Biochem. Physiol. 35, 339-346) inhibition, three distinct groups could be established using succinyl choline as substrate. These results are comparable with the standard optical method of Kalow & Genest (cf. above) using benzoyl choline as substrate.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168694

Source DB:  PubMed          Journal:  Z Klin Chem Klin Biochem        ISSN: 0044-2933


  5 in total

1.  The use of serum cholinesterase in succinylcholine apnoea.

Authors:  K L Scholler; H W Goedde; H G Benkmann
Journal:  Can Anaesth Soc J       Date:  1977-05

Review 2.  Pharmacogenetics and ecogenetics.

Authors:  D P Agarwal; H W Goedde
Journal:  Experientia       Date:  1986-10-15

3.  A note on suxamethonium sensitivity and serum cholinesterase variants.

Authors:  D P Agarwal; L M Srivastava; H W Goedde
Journal:  Hum Genet       Date:  1976-04-15       Impact factor: 4.132

4.  Cholinesterase Newfoundland: a new succinylcholine-sensitive variant of cholinesterase at locus 1.

Authors:  N E Simpson; C R Elliott
Journal:  Am J Hum Genet       Date:  1981-05       Impact factor: 11.025

5.  Suxamethonium-the development of a modern drug from 1906 to the present day.

Authors:  H R Dorkins
Journal:  Med Hist       Date:  1982-04       Impact factor: 1.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.